C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease

Respirology

Volumn 13, Issue 7, 2008, Pages 1028-1033

  Ruiz González, Agustín ^a,b   Lacasta, Daniel ^a   Ibarz, Mercedes ^a   MartÍnez Alonso, Montserrat ^a   Falguera, Miquel ^a   Porcel, José M ^a  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b NONE   (Spain)

Author keywords

Biomarker; COPD; CRP; Exacerbation; Prognosis

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; BRONCHODILATING AGENT; C REACTIVE PROTEIN; CORTICOSTEROID DERIVATIVE; IPRATROPIUM BROMIDE; SALBUTAMOL;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONFUSION; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORTALITY; OUTCOME ASSESSMENT; OXYGEN SUPPLY; PATIENT TRANSPORT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; ROC CURVE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 54349098262     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01403.x     Document Type: Article

References (21)

1. Global Initiative for Chronic Obstructive Lung Disease. 2006. [Accessed 1 March 2007.] Available from URL: http://www.goldcopd.com.
2. Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic bronchitis and COPD. A 1-year follow-up study. Chest 2003 123 : 784 91.
3. Connors AF, Dawson NV, Thomas C, Harrell FE, Desbiens N et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 1996 154 : 959 67.
4. McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute exacerbations of COPD. A summary and appraisal of published evidence. Chest 2001 119 : 1190 209.
5. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur. Respir. J. 2001 17 : 1112 19.
6. Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am. J. Crit Care Med. 2006 174 : 867 74.
7. Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 2007 131 : 1058 67.
8. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987 106 : 196 204.
9. Cleveland WS. LOWESS: A program for smoothing scatterplots by robust locally weighted regression. Am Stat. (TAS) 1981 35 : 54.
10. Groenewegen KH, Schols AMWJ, Wouters EFM. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003 124 : 459 67.
11. Gunen H, Hacievliyagil SS, Kosar F. Factors affecting survival of hospitalised patients with COPD. Eur. Respir. J. 2005 26 : 234 41.
12. Dev D, Wallace E, Sankaran R, Cunniffe J, Govan JR et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir. Med. 1998 92 : 664 67.
13. Weis N, Almdal T. C-reactive protein: can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease. Eur. J. Intern. Med. 2006 17 : 88 91.
14. Stokley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000 117 : 1638 45.
15. Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006 61 : 849 53.
16. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, et al. C-reactive protein as a predictor of prognosis in COPD. Am. J. Respir. Crit. Care Med. 2007 175 : 250 5.
17. Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R et al. C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998 24 : 1052 6.
18. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M et al. Guidelines for the management of adult lower respiratory tract infections. Eur. Respir. J. 2005 136 : 434 40.
19. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004 170 : 760 5.
20. Smith RP, Lipworth BJ. C-reactive protein in simple community-acquired pneumonia. Chest 1995 107 : 1028 31.
21. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur. Respir. J. 2007 29 : 1224 38.